Introduction Graft-versus-host disease (GVHD) is a major barrier to the success of hematopoietic stem cell

Introduction Pure red cell aplasia (PRCA) is a rare but serious complication occurring in 7–10%

Introduction Intra-patient variability (IPV) in tacrolimus blood concentrations has emerged as a potential biomarker for

Introduction Allogeneic hematopoietic cell transplantation (HCT) is a curative treatment for severe aplastic anemia (SAA),

Introduction Acquired aplastic anemia (AA) is an immune-mediated bone marrow failure caused by a cytotoxic

Introduction (Article introduction authored by Conquest Editorial Team) Over the past 50 years, aplastic anemia

Introduction (Article introduction authored by Conquest Editorial Team) Acquired aplastic anemia (AA) in children is

Introduction (Article introduction authored by Conquest Editorial Team) Aplastic anemia (AA) is a severe hematopoietic

Introduction (Article introduction authored by Conquest Editorial Team) Chronic graft-versus-host disease (GvHD) treatment response is

Introduction (Article introduction authored by Conquest Editorial Team) Graft versus host disease (GVHD) is a

Introduction Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a vital treatment for various benign and

Introduction The TERC gene is vital for maintaining telomeres, and reduced TERC levels can lead

Introduction Ocular graft-versus-host-disease (GVHD) remains a significant clinical complication after allogeneic hematopoietic stem cell transplantation.

Introduction Acquired aplastic anemia (AA) is a rare, life-threatening condition in children that results from

Introduction Graft-versus-host disease (GvHD) is a major problem in patients undergoing allogeneic hematopoietic stem cell

Introduction Aplastic anemia (AA) is an auto-activated T cell-mediated bone marrow failure. Cyclosporine is often

Introduction It’s not unusual to receive a cancer diagnosis along with a pericardial effusion. The

Introduction Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the most successful curative therapy for a

Abstract The typical bone marrow failure syndrome, aplastic anaemia (AA), can be either acquired or

Abstract Hematopoietic cell transplantation (HCT) has significantly improved the prognosis for patients with severe aplastic

Introduction In this context, despite significant progress in the optimization of allogeneic hematopoietic stem cell

Introduction Acquired aplastic anemia (AA) is an immune-mediated bone marrow failure syndrome mediated by cytotoxic